Presentations | Sutro Biopharma, Inc.

Bristol Myers Squibb Investor Series

Bristol Myers Squibb Investor Series Bristol Myers Squibb Investor Series - Hematology June 25, 2020 at 11:30am ET WEBCAST View This Presentation Bristol Myers Squibb Investor Series - Early Pipeline and Immuno-Oncology June 22, 2020 at 11:30am ET WEBCAST View...

M1231: A First In-Class Bispecific ADC Targeting EGFR and MUC1 Presented by EMD Serono at American Association for Cancer Research (AACR) Virtual Meeting II on June 24, 2020 – Presentation

Events, News, Presentations

M1231: A First In-Class Bispecific ADC Targeting EGFR and MUC1 Presented by EMD Serono at American Association for Cancer Research (AACR) Virtual Meeting II on June 24, 2020 – Presentation AACR requires pre-registration to access this presentation. Oral...

American Association for Cancer Research (AACR) 2020 Virtual Meeting II – Abstract

News, Presentations

American Association for Cancer Research (AACR) 2020 Virtual Meeting II – Abstract STRO-002, An Anti-FolRα ADC, Demonstrates Immune-Modulating Properties and Potentiates PD-L1 Blockade Millicent Embry*, Sihong Zhou*, Christine Cheng, Janice Yu, Cristina...

American Association for Cancer Research (AACR) 2020 Virtual Meeting II – Poster

News, Presentations

American Association for Cancer Research (AACR) 2020 Virtual Meeting II – Poster STRO-002, An Anti-FolRα ADC, Demonstrates Immune-Modulating Properties and Potentiates PD-L1 Blackade Please Click the Link, STRO-002 AACR 2020 Poster to Enlarge Please click link...

Sutro Biopharma Presents New Preclinical Data at 2020 AACR Virtual Annual Meeting II Suggesting Synergy between its STRO-002 Antibody-Drug Conjugate and Immune Checkpoint Inhibitors Resulting in Tumor Regression and Adaptive Anti-Tumor Immunity

Events, News, Presentations, Press Releases

Sutro Biopharma Presents New Preclinical Data at 2020 AACR Virtual Annual Meeting II Suggesting Synergy between its STRO-002 Antibody-Drug Conjugate and Immune Checkpoint Inhibitors Resulting in Tumor Regression and Adaptive Anti-Tumor Immunity Additionally, Sutro’s...

Sutro Biopharma to Present New Preclinical Data on its STRO-002 Antibody-Drug Conjugate at the Upcoming AACR 2020 Virtual Meeting on June 22, 2020

Events, News, Presentations, Press Releases

Sutro Biopharma to Present New Preclinical Data on its STRO-002 Antibody-Drug Conjugate at the Upcoming AACR 2020 Virtual Meeting on June 22, 2020 Additionally, Sutro’s partner Merck KGaA, Darmstadt, Germany, will be unveiling preclinical data from the collaboration’s...

« Older Entries

Next Entries »